Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

NCT04526730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Tavo
DRUG: Nivolumab
DEVICE: OncoSec Medical Electroporation Therapy System

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]